# Response to commentary on “pembrolizumab in gestational trophoblastic neoplasia: systematic review and meta-analysis with sub-group analysis of potential prognostic factors”

**Authors:** Marcio Barcellos, Antonio Braga, Matheus Machado Rech, Solange Artimos de Oliveira, Jose Mauro Madi, Sue Yazaki Sun, Jorge de Rezende-Filho, Kevin M. Elias, Neil S. Horowitz, Ross S. Berkowitz

PMC · DOI: 10.1016/j.clinsp.2025.100713 · Clinics · 2025-06-27

## Full-text entities

- **Diseases:** gestational trophoblastic neoplasia (MESH:D031901)
- **Chemicals:** pembrolizumab (MESH:C582435)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12266472/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12266472/full.md

---
Source: https://tomesphere.com/paper/PMC12266472